Summitry LLC Abb Vie Inc. Transaction History

Summitry LLC

$1.94 Billion
Q3 2024

A detailed history of Summitry LLC transactions in Abb Vie Inc. stock. As of the latest transaction made, Summitry LLC holds 4,163 shares of ABBV stock, worth $725,902. This represents 0.04% of its overall portfolio holdings.

Number of Shares

4,163

Previous 2,618 59.01%

Holding current value

$725,902

Previous $449,000 83.07%

% of portfolio

0.04%

Previous 0.02%

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 07, 2024	BUY	$163.84 - $199.33 $253,132 - $307,964	1,545 Added 59.01%	4,163 $822,000
Q2 2024 Aug 09, 2024	SELL	$154.79 - $180.76 $49,532 - $57,843	-320 Reduced 10.89%	2,618 $449,000
Q1 2024 May 06, 2024	SELL	$159.82 - $182.1 $152,628 - $173,905	-955 Reduced 24.53%	2,938 $535,000
Q4 2023 Feb 07, 2024	BUY	$137.6 - $154.97 $2,064 - $2,324	15 Added 0.39%	3,893 $603,000
Q3 2023 Nov 03, 2023	SELL	$133.59 - $154.65 $3,740 - $4,330	-28 Reduced 0.72%	3,878 $578,000
Q2 2023 Aug 07, 2023	SELL	$132.51 - $164.9 $3,180 - $3,957	-24 Reduced 0.61%	3,906 $526,000
Q1 2023 May 11, 2023	SELL	$144.61 - $166.54 $3,904 - $4,496	-27 Reduced 0.68%	3,930 $626,000
Q4 2022 Feb 09, 2023	SELL	$138.31 - $165.87 $14,107 - $16,918	-102 Reduced 2.51%	3,957 $639,000
Q3 2022 Nov 09, 2022	BUY	$134.21 - $153.93 $89,920 - $103,133	670 Added 19.77%	4,059 $545,000
Q4 2021 Feb 10, 2022	BUY	$107.43 - $135.93 $364,080 - $460,666	3,389 New	3,389 $459,000
Q2 2021 Aug 13, 2021	SELL	$105.21 - $117.21 $429,256 - $478,216	-4,080 Closed	0 $0
Q1 2021 May 12, 2021	SELL	$102.3 - $112.62 $818 - $900	-8 Reduced 0.2%	4,080 $442,000
Q4 2020 Feb 05, 2021	BUY	$80.49 - $108.67 $24,710 - $33,361	307 Added 8.12%	4,088 $438,000
Q3 2020 Nov 12, 2020	SELL	$85.91 - $100.83 $24,913 - $29,240	-290 Reduced 7.12%	3,781 $331,000
Q2 2020 Aug 07, 2020	BUY	$73.37 - $98.18 $298,689 - $399,690	4,071 New	4,071 $400,000

Others Institutions Holding ABBV

# of Institutions

3,850

Shares Held

1.25B

Call Options Held

16.8M

Put Options Held

12.2M

View Full List

About AbbVie Inc.

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $308B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

More about ABBV

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Summitry LLC, based on Form 13F filings with the SEC.

News

Stay updated on Summitry LLC with notifications on news.

Account